La cellule souche cancéreuse: Un pilote aux commandes du cancer du sein

Christophe Ginestier; Hasan Korkaya; Gabriela Dontu; Daniel Birnbaum; Max S. Wicha; Emmanuelle Charafe-Jauffret

doi:10.1051/medsci/200723121133

La cellule souche cancéreuse: Un pilote aux commandes du cancer du sein

Translated title of the contribution: The cancer stem cell: The breast cancer driver

Christophe Ginestier, Hasan Korkaya, Gabriela Dontu, Daniel Birnbaum, Max S. Wicha, Emmanuelle Charafe-Jauffret

Research output: Contribution to journal › Review article › peer-review

20 Scopus citations

Abstract

Recent research in a large variety of tumors, including breast cancer, has given support to the "cancer stem cell hypothesis". Based on this, tumors contain and are driven by a cellular subcomponent that retains key stem cell properties. These include self-renewal, which drives tumorigenesis, and the capacity to generate cellular heterogeneity. Recently, different techniques have been used to isolate potential breast cancer stem cells with the cell surface phenotype CD44⁺CD24^-/lowlin^- or expressing Aldehyde dehydrogenase. This model has fundamental implications for breast cancer treatment. The development of specific therapeutics that target this population is an important focus for the future.

Translated title of the contribution	The cancer stem cell: The breast cancer driver
Original language	French
Pages (from-to)	1133-1139
Number of pages	7
Journal	Medecine/Sciences
Volume	23
Issue number	12
DOIs	https://doi.org/10.1051/medsci/200723121133
State	Published - Dec 2007
Externally published	Yes

ASJC Scopus subject areas

Biochemistry, Genetics and Molecular Biology(all)

Access to Document

10.1051/medsci/200723121133

Cite this

@article{6e1cbf9e9d194528a0f2f0616c1ab36c,

title = "La cellule souche canc{\'e}reuse: Un pilote aux commandes du cancer du sein",

abstract = "Recent research in a large variety of tumors, including breast cancer, has given support to the {"}cancer stem cell hypothesis{"}. Based on this, tumors contain and are driven by a cellular subcomponent that retains key stem cell properties. These include self-renewal, which drives tumorigenesis, and the capacity to generate cellular heterogeneity. Recently, different techniques have been used to isolate potential breast cancer stem cells with the cell surface phenotype CD44+CD24-/lowlin- or expressing Aldehyde dehydrogenase. This model has fundamental implications for breast cancer treatment. The development of specific therapeutics that target this population is an important focus for the future.",

author = "Christophe Ginestier and Hasan Korkaya and Gabriela Dontu and Daniel Birnbaum and Wicha, {Max S.} and Emmanuelle Charafe-Jauffret",

year = "2007",

month = dec,

doi = "10.1051/medsci/200723121133",

language = "French",

volume = "23",

pages = "1133--1139",

journal = "Medecine/Sciences",

issn = "0767-0974",

publisher = "Editions EDK",

number = "12",

}

TY - JOUR

T1 - La cellule souche cancéreuse

T2 - Un pilote aux commandes du cancer du sein

AU - Ginestier, Christophe

AU - Korkaya, Hasan

AU - Dontu, Gabriela

AU - Birnbaum, Daniel

AU - Wicha, Max S.

AU - Charafe-Jauffret, Emmanuelle

PY - 2007/12

Y1 - 2007/12

N2 - Recent research in a large variety of tumors, including breast cancer, has given support to the "cancer stem cell hypothesis". Based on this, tumors contain and are driven by a cellular subcomponent that retains key stem cell properties. These include self-renewal, which drives tumorigenesis, and the capacity to generate cellular heterogeneity. Recently, different techniques have been used to isolate potential breast cancer stem cells with the cell surface phenotype CD44+CD24-/lowlin- or expressing Aldehyde dehydrogenase. This model has fundamental implications for breast cancer treatment. The development of specific therapeutics that target this population is an important focus for the future.

AB - Recent research in a large variety of tumors, including breast cancer, has given support to the "cancer stem cell hypothesis". Based on this, tumors contain and are driven by a cellular subcomponent that retains key stem cell properties. These include self-renewal, which drives tumorigenesis, and the capacity to generate cellular heterogeneity. Recently, different techniques have been used to isolate potential breast cancer stem cells with the cell surface phenotype CD44+CD24-/lowlin- or expressing Aldehyde dehydrogenase. This model has fundamental implications for breast cancer treatment. The development of specific therapeutics that target this population is an important focus for the future.

UR - http://www.scopus.com/inward/record.url?scp=37849031304&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=37849031304&partnerID=8YFLogxK

U2 - 10.1051/medsci/200723121133

DO - 10.1051/medsci/200723121133

M3 - Review article

C2 - 18154716

AN - SCOPUS:37849031304

VL - 23

SP - 1133

EP - 1139

JO - Medecine/Sciences

JF - Medecine/Sciences

SN - 0767-0974

IS - 12

ER -

La cellule souche cancéreuse: Un pilote aux commandes du cancer du sein

Abstract

ASJC Scopus subject areas

Access to Document

Other files and links

Fingerprint

Cite this